Tamtam Try Tamtam free
Arjo logo

Arjo account plan

Healthcare equipment solutions

At a glance

Arjo is a Swedish supplier of patient mobility medical devices, rental and service, with SEK 11,000 M net sales in 2025 and about 7,000 employees.

Arjo AB is a Malmö-based medical device company, listed on Nasdaq Stockholm, that helps caregivers move and reposition patients, prevent pressure injuries and venous thromboembolism (VTE), and support hygiene. Its customers are public and private acute care (68% of 2025 sales) and long-term care (32%) institutions in more than 100 countries; the largest markets are the US, UK, France, Canada and Germany. In 2025, net sales were SEK 11,000 M (11,292), with organic growth of 3.4%, an adjusted EBITDA margin of 17.5% and net profit of SEK 334 M. Sales split 39% capital goods, 25% rental, 20% service and 16% disposables, and the group had an average of 6,942 employees. Carl Bennet AB is the largest shareholder, and Andréas Elgaard has been President and CEO since January 7, 2026.

Business units

Strategic priorities

SEK 350 M EBIT improvement
Arjo commits to improve EBIT by approximately SEK 350 M versus 2025, from a more effective operating model, procurement and commercial efficiency, with effects from 2027 and full effect by mid-2029; it does not depend on future growth.
Win where it has the right to play
Own and expand leadership in long-term care, strengthen and scale acute care, its largest sector, and expand selectively into new care settings such as home care.
Simplify to amplify
Prune a long tail of products, narrow variations in pricing and margins, improve commercial excellence and speed to market.
Digital and AI-enabled care partner
Use digital tools and AI mainly for internal processes and efficiency, and also in the offer; management notes most products are not connected today.
New financial targets
Updated targets for growth, profitability and capital efficiency follow in Q1 2027; the 2026 outlook is organic growth within the 3–5% target interval.

Latest results

In Q3 2026, net sales rose to SEK 2,849 M (2,646), an organic increase of 6.0%, led by North America and Europe and by patient handling. Gross margin rose to 43.0% (41.1), helped by a US tariff refund of approximately SEK 35 M, and adjusted EBITDA reached SEK 523 M with an 18.4% margin. Net profit fell to SEK 58 M (81) after a SEK 62 M revaluation of the Atlas Mobility and Veplas holdings, both now valued at zero. For January–September 2026, net sales were SEK 8,306 M with organic growth of 4.8% and net profit of SEK 291 M (264). Net debt/adjusted EBITDA stood at 2.2, and Arjo expects 2026 organic growth within the 3–5% interval.

Investments and deals

Restructuring programme
Restructuring costs of approximately SEK 370 M are expected, primarily over the next 18 months from Q3 2026, to fund the new operating model.
Rental fleet
Net investments were SEK 177 M in Q3 2026, including SEK 76 M in the rental fleet.
Tasmania service acquisition
In Q2 2026 Arjo acquired a service business in Tasmania from MD Engineering Solutions for about SEK 30 M.
New regional operating model
Five regional managers joined the Management Team from July 1, 2026, and new Group Sales, Group Portfolio and Group Operations functions were set up.
R&D and new products
R&D costs were SEK 303 M in 2025, 2.8% of net sales; launches included the Maxi Move 5 floor lift and the Symbliss bathing system, and FDA 510(k) clearances in fetal monitoring.

Challenges and risks

Profitability below target
The adjusted EBITDA margin was 17.5% in 2025 against a target of about 23%, and cash conversion of 79.3% missed the >80% target; the CEO said "We are not good enough."
US tariffs and currency
The weaker US dollar and US tariffs weighed on 2025 gross margin; currency risk is named the most material financial risk.
Healthcare funding and reimbursement
Political decisions can limit healthcare funding, as in the UK in 2025, and some markets depend on reimbursement approval.
Pricing pressure
In US VTE compression the average price level has dropped significantly with tough new competition.
Supply chain and transport costs
Higher material and transportation costs weighed on gross margin in 2026, and suppliers of direct materials sit in more than 50 countries.

What leadership says

“Arjo has promised things in the past, and we have not delivered. This time, we're going to deliver.”

Andréas Elgaard, President & CEO · Capital Markets Day, Stockholm, September 24, 2026

“The strategy is really all about a plan to put Arjo back on track”

Andréas Elgaard, President & CEO · Q3 2026 earnings call, October 22, 2026

“With 6% organic growth in the quarter, we continue to grow and strengthen our profitability. Our focus now is on turning our strategy into results and gradually building a stronger Arjo for the future.”

Andréas Elgaard, President & CEO · Interim Report January–September 2026, October 22, 2026

“We are setting a new direction to strengthen our market position, our offering and our efficiency going forward.”

Andréas Elgaard, President & CEO · Annual and Sustainability Report 2025, March 30, 2026

Where a supplier can help

Procurement and cost savings
Procurement is one of the named levers of the SEK 350 M EBIT commitment, so suppliers that lower material, component or transport costs can align with that programme.
Digital and AI for internal efficiency
The ambition to become a digital and AI-enabled care partner, mainly for internal processes, opens room for software, automation and data vendors.
Commercial excellence tools
The new Group Sales function and the push to narrow pricing and margin variations call for pricing, CRM and sales enablement support.
Logistics and supply chain
Higher transportation costs and a new transportation management system point to needs in freight, warehousing and supply chain optimisation.
Portfolio rationalisation
Pruning a long tail of products and faster speed to market create demand for product lifecycle, engineering and regulatory services.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Arjo?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Arjo

What does Arjo do?

Arjo supplies medical devices and solutions for patient mobility: patient handling lifts, medical beds, pressure injury prevention surfaces, hygiene systems and VTE prevention, sold, rented and serviced for acute and long-term care providers in more than 100 countries.

What is Arjo's revenue?

Net sales were SEK 11,000 M in 2025 (11,292), with organic growth of 3.4%. For January–September 2026 net sales were SEK 8,306 M, up 4.8% organically.

How many employees does Arjo have?

About 7,000, with an average of 6,942 in 2025.

Who is Arjo's CEO?

Andréas Elgaard has been President and CEO since January 7, 2026; Johan Malmquist chairs the Board.

What is Arjo's strategy?

A strategy presented in September 2026 focuses on long-term and acute care, simplifying the portfolio and becoming a digital and AI-enabled care partner, with a commitment to improve EBIT by approximately SEK 350 M versus 2025 by mid-2029.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)